Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Gensight scouts a $100M IPO for its ocular gene therapies
Gensight scouts a $100M IPO for its ocular gene therapies
Gensight scouts a $100M IPO for its ocular gene therapies
Submitted by
admin
on July 8, 2015 - 11:35am
Source:
Fierce Biotech
News Tags:
Gensight Biologics
IPOs
ocular gene therapies
gene therapy
Headline:
Gensight scouts a $100M IPO for its ocular gene therapies
Do Not Allow Advertisers to Use My Personal information
